Your search returned 7 results.

Results
	1.	Alert systems for post-marketing surveillance of adverse drug reactions. [electronic resource] by Praus, M Schindel, F Fescharek, R Schwarz, S Producer: 19940421 In: Statistics in medicine vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. [electronic resource] by Praus, M Wauterickx, K Collen, D Gerard, R D Producer: 19990817 In: Gene therapy vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Two-dimensional maps in the most extended (pH 2.5-11) immobilized pH gradient interval. [electronic resource] by Sinha, P K Praus, M Köttgen, E Gianazza, E Righetti, P G Producer: 19910228 In: Journal of biochemical and biophysical methods vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. [electronic resource] by Harabacz, I Bock, H Jüngst, C Klockmann, U Praus, M Weber, R Producer: 19920507 In: Vaccine vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Ksp-cadherin is a functional cell-cell adhesion molecule related to LI-cadherin. [electronic resource] by Wendeler, M W Praus, M Jung, R Hecking, M Metzig, C Gessner, R Producer: 20040505 In: Experimental cell research vol. 294 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization. [electronic resource] by Klockmann, U Bock, H L Kwasny, H Praus, M Cihlová, V Tomková, E Krivanec, K Producer: 19910501 In: Vaccine vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. [electronic resource] by Bajou, K Masson, V Gerard, R D Schmitt, P M Albert, V Praus, M Lund, L R Frandsen, T L Brunner, N Dano, K Fusenig, N E Weidle, U Carmeliet, G Loskutoff, D Collen, D Carmeliet, P Foidart, J M Noël, A Producer: 20010521 In: The Journal of cell biology vol. 152 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)